Subscribe to the gold package and get unlimited access to Shamra Academy
Register a new userBiocompatible Two-dimensional Titanium Nanosheets for Efficient Plasmonic Photothermal Cancer Therapy
192
0
0.0
(
0
)
Ask ChatGPT about the research
No Arabic abstract
Photothermal therapy (PTT) has shown significant potential in cancer treatment. However, developing nanomaterial-based photothermal agents with good biocompatibility and high photothermal conversion efficiency (PTCE) remains a key challenge. Titanium has been widely employed as biomedical materials based on their excellent biocompatibility. In this work, the titanium based plasmonic photothermal therapy (Ti-PPTT) is demonstrated. Using the liquid-phase exfoliation (LPE), the metallic Ti can be fabricated into the two-dimensional (2D) nanosheets (NSs), similar to exfoliating other layered 2D materials. The 2D Ti NSs exhibited good biocompatibility, high extinction coefficient of 20.8 Lg-1cm1 and high PTCE of 73.4%, owing to localized surface plasmon resonances (LSPR); which is significantly higher than other photothermal agents, including Au (21%), MoS2 (24.4%), BP (28.4%) and Ti3C2 MXene (30.6%). Consequently, 2D Ti-PPTT exhibited a notable therapeutic effect in a human hepatocellular carcinoma model without side effects. Our study could pave a new avenue for PTT using metal Ti and arouse a wide interest in the potential efficient PTT for other elemental transition metals owing to their LSPR. Furthermore, the efficient photothermal effect and environmental friendliness of Ti NSs make them deserve more research toward other application, such as solar energy harvesting and sea water desalination.
rate research
Read More
Synaptic devices with linear high-speed switching can accelerate learning in artificial neural networks (ANNs) embodied in hardware. Conventional resistive memories however suffer from high write noise and asymmetric conductance tuning, preventing parallel programming of ANN arrays as needed to surpass conventional computing efficiency. Electrochemical random-access memories (ECRAMs), where resistive switching occurs by ion insertion into a redox-active channel address these challenges due to their linear switching and low noise. ECRAMs using two-dimensional (2D) materials and metal oxides suffer from slow ion kinetics, whereas organic ECRAMs enable high-speed operation but face significant challenges towards on-chip integration due to poor temperature stability of polymers. Here, we demonstrate ECRAMs using 2D titanium carbide (Ti3C2Tx) MXene that combines the high speed of organics and the integration compatibility of inorganic materials in a single high-performance device. Our ECRAMs combine the speed, linearity, write noise, switching energy and endurance metrics essential for parallel acceleration of ANNs, and importantly, they are stable after heat treatment needed for back-end-of-line integration with Si electronics. The high speed and performance of these ECRAMs introduces MXenes, a large family of 2D carbides and nitrides with more than 30 compositions synthesized to date, as very promising candidates for devices operating at the nexus of electrochemistry and electronics.
This paper reports on the conclusions of a 2013 Joint DOE/NCI Workshop, and translates clinical accelerator facility requirements into accelerator and beam-delivery technical specifications. Available or feasible accelerator technologies are compared, including a new concept for a compact, CW, and variable energy light ion accelerator currently under development. This new light ion accelerator is based on advances in non-scaling Fixed-Field Alternating gradient (FFAG) accelerator design. The new design concepts combine isochronous orbits with long (up to 4m) straight sections in a compact racetrack format allowing inner circulating orbits to be energy selected for low-loss, CW extraction, effectively eliminating the high-loss energy degrader in conventional CW cyclotron designs.
Cancer and healthy cells have distinct distributions of molecular properties and thus respond differently to drugs. Cancer drugs ideally kill cancer cells while limiting harm to healthy cells. However, the inherent variance among cells in both cancer and healthy cell populations increases the difficulty of selective drug action. Here we propose a classification framework based on the idea that an ideal cancer drug should maximally discriminate between cancer and healthy cells. We first explore how molecular markers can be used to discriminate cancer cells from healthy cells on a single cell basis, and then how the effects of drugs are statistically predicted by these molecular markers. We then combine these two ideas to show how to optimally match drugs to tumor cells. We find that expression levels of a handful of genes suffice to discriminate well between individual cells in cancer and healthy tissue. We also find that gene expression predicts the efficacy of cancer drugs, suggesting that the cancer drugs act as classifiers using gene profiles. In agreement with our first finding, a small number of genes predict drug efficacy well. Finally, we formulate a framework that defines an optimal drug, and predicts drug cocktails that may target cancer more accurately than the individual drugs alone. Conceptualizing cancer drugs as solving a discrimination problem in the high-dimensional space of molecular markers promises to inform the design of new cancer drugs and drug cocktails.
The possibility of using Nitrogen-vacancy centers in diamonds to measure nanoscale magnetic fields with unprecedented sensitivity is one of the most significant achievements of quantum sensing. Here we present an innovative experimental set-up, showing an achieved sensitivity comparable to the state of the art ODMR protocols if the sensing volume is taken into account. The apparatus allows magnetic sensing in biological samples such as individual cells, as it is characterized by a small sensing volume and full bio-compatibility. The sensitivity at different optical powers is studied to extend this technique to the intercellular scale.
The metal diborides are a class of ceramic materials with crystal structures consisting of hexagonal sheets of boron atoms alternating with planes of metal atoms held together with mixed character ionic/covalent bonds. Many of the metal diborides are ultrahigh temperature ceramics like HfB$_2$, TaB$_2$, and ZrB$_2$, which have melting points above 3000$^circ$C, high mechanical hardness and strength at high temperatures, and high chemical resistance, while MgB$_2$ is a superconductor with a transition temperature of 39 K. Here we demonstrate that this diverse family of non-van der Waals materials can be processed into stable dispersions of two-dimensional (2D) nanosheets using ultrasonication-assisted exfoliation. We generate 2D nanosheets of the metal diborides AlB$_2$, CrB$_2$, HfB$_2$, MgB$_2$, NbB$_2$, TaB$_2$, TiB$_2$, and ZrB$_2$, and use electron and scanning probe microscopies to characterize their structures, morphologies, and compositions. The exfoliated layers span up to micrometers in lateral dimension and reach thicknesses down to 2-3 nm, while retaining their hexagonal atomic structure and chemical composition. We exploit the convenient solution-phase dispersions of exfoliated CrB$_2$ nanosheets to incorporate them directly into polymer composites. In contrast to the hard and brittle bulk CrB$_2$, we find that CrB$_2$ nanocomposites remain very flexible and simultaneously provide increases in the elastic modulus and the ultimate tensile strength of the polymer. The successful liquid-phase production of 2D metal diborides enables their processing using scalable low-temperature solution-phase methods, extending their use to previously unexplored applications, and reveals a new family of non-van der Waals materials that can be efficiently exfoliated into 2D forms.
Log in to be able to interact and post comments
comments
Fetching comments
Sign in to be able to follow your search criteria
